Startup Company Finance

As business owners know, raising capital is essential to the survival and long-term success of startup and early-stage companies. Depending on the industry, stage of development, and the growth and exit goals of its principals, early-stage companies have numerous financing instruments from which to choose. From straightforward friends & family and seed financings, to multi-round convertible note financings and SAFEs, to more advanced series financing rounds with institutional investors, Sam has assisted both early-stage companies and investors in all manners of financing transactions.

Representative Transactions

  • Represented public-private partnership in more than 40 equity and convertible debt investments in startup companies based in Missouri (2012-present)
  • Regularly assisted startup companies in obtaining seed equity financing though St. Louis-based business incubator program (2015-present)
  • Represented large national health insurer in Series B financing round investment (April 2024)
  • Represented minority investor in Series D financing round investment in pet products company (March 2024)
  • Represented investor in startup company SAFE offering (March 2024)
  • Represented large national health insurer in Convertible Note financing investment (January 2024)
  • Represented large national health insurer in Series C financing round investment (November 2023)
  • Represented investor in small Convertible Note financing round (October 2023)
  • Represented large national health insurer in Series A financing round investment (September 2023)
  • Represented large national health insurer in Series B financing round investment (August 2023)
  • Represented large national health insurer in Convertible Note financing investment (June 2023)
  • Represented large national health insurer in Series B financing round investment (May 2023)
  • Represented local real estate technology company in Series B-1 financing round (March 2023)
  • Represented St. Louis-area startup company in Series C financing round (March 2023)
  • Represented large national health insurer in Series Seed financing round investment (March 2023)
  • Represented startup technology company with respect to participation in incubator program (December 2022)
  • Represented large national health insurer in $50 million warrant investment (November 2022)
  • Represented newly established investment fund of large St. Louis-based company in Series Seed financing round (August 2022)
  • Represented large national health insurer in limited partnership joint venture investment (July 2022)
  • Represented public company as lead investor in Series B financing round of technology company (June 2022)
  • Represented large national health insurer in secondary acquisition of preferred stock of technology startup (May 2022)
  • Represented large national health insurer in preferred stock investment in technology startup (February 2022)
  • Represented large national health insurer in convertible note investment (January 2022)
  • Represented international company in SAFE investment in startup social justice company (January 2022)
  • Represented men’s grooming company in Series A-1 financing round (December 2021)
  • Represented St. Louis-based agricultural technology company in Series A-1 financing round (November 2021)
  • Represented large national health insurer in debt and equity investment in technology company (September 2021)
  • Represented local real estate technology company in Series B financing round (September 2021)
  • Represented large national health insurer in debt and equity investment in Swedish health care technology company (July 2021)
  • Represented large national health insurer in acquisition of warrants to purchase preferred stock of a primary vendor (June 2021)
  • Represented public relations startup company with initial friends and family round financing (April 2021)
  • Represented large national health insurer in Series B investment (April 2021)
  • Represented local software company in secondary acquisition of Series B Preferred Stock (February 2021)
  • Represented regional craft brewer in joint venture and financing transaction (September 2020)
  • Represented large national healthcare company in equity investment in healthcare software company (July 2020)
  • Represented men’s grooming products company in conversion to Delaware corporation and subsequent Series A financing round (June 2020)
  • Represented large national healthcare company in Series B-3 stock investment in digital technology healthcare company (May 2020)
  • Represented large national healthcare company in investment in an early stage healthcare investment fund (April 2020)
  • Represented large national healthcare company in Series B stock investment in Medicaid LTSS company (March 2020)
  • Represented Missouri-based consumer services technology company in conversion to Delaware corporation and subsequent participation in tech incubator program (November 2019)
  • Represented large national healthcare company in Series B-2 round investment in healthcare technology company (August 2019)
  • Represented large national healthcare company in preferred stock investment in startup health services company (July 2019)
  • Represented regional grooming products company with Series Preferred Stock financing and subsequent conversion to Delaware corporation and Series A Preferred Stock financing (September 2018 – February 2019)
  • Represented small technology startup with friends and family financing round (December 2018)
  • Represented St. Louis-based technology company in Series A Financing round and related conversion to Delaware corporation (November 2018)
  • Represented investor in convertible note financing for a California-based retail purchasing app startup (July 2018).
  • Represented St. Louis-based tech company in Series B Preferred Stock financing (July 2018)
  • Represented Los Angeles-based investor in Series A round investment in California-based beverage services technology company (June 2018)
  • Represented large national healthcare company in note and warrant offering of startup health services company (April 2018)
  • Represented seed-stage food and beverage company in convertible note financing of approximately (March 2018)
  • Represented St. Louis-based web app company with multiple rounds of convertible note offerings (2015-2018)
  • Represented startup web app in Series A financing as part of a venture capital accelerator program (November 2017)
  • Represented large national healthcare company in investment in common stock of startup health services company (August 2017)